Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance
Giordano Madeddu(University of Sassari), Paolo Bonfanti(University of California San Diego), Tiziana Quirino(Ospedale di Circolo di Busto Arsizio), Paolo Maggi(Università degli Studi di Enna Kore), Chiara Dentone(Ospedale di Sanremo), Benedetto Maurizio Celesia(Ospedale Garibaldi), Laura Carenzi(Luigi Sacco Hospital), Giancarlo Orofino(Ospedale Amedeo di Savoia), Francesca Vichi, Giuseppe Vittorio De Socio(University of Perugia), Elena Ricci(Mario Negri Institute for Pharmacological Research), Canio Martinelli(Azienda Ospedaliero-Universitaria Careggi), Marco Franzetti, Giustino Parruti(Azienda USL di Pescara), Giovanni Penco(Ente Ospedaliero Ospedali Galliera), Antonio Di Biagio, Raffaella Libertone(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Paola Bagella(Azienda Ospedaliero-Universitaria Careggi)
Cited by 30
Related Papers
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
|CHEST Journal|2021|404
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|394
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>
|Clinical Infectious Diseases|2018|351